Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diponecaftor in Cystic Fibrosis (CHOICES)
NCT06468527Phase 2Completed
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial of diponecaftor in cystic fibrosis (CF). Started Jun 2024; status: completed.
02
Drugs
diponecaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT06468527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06468527.